U.S. President Donald J. Trump provided hope on Monday to millions of Americans by addressing the Corona Virus vaccine status from Morrisville, North Carolina, at the Fujifilm Diosynth Biotechnologies facility where it will be produced.
The President said his administration has made great progress under “Operation Warp Speed — our historic initiative to develop, test, manufacture, and deliver a vaccine in record time.”
“The Moderna vaccine has officially entered phase three already. And that’s phase three clinical trials: the final stage before approval,” he said.
“America will develop a vaccine very soon, and we will defeat the virus. We will have it delivered in record time.” – President Trump
Trump continued, “A second vaccine is likely to enter phase three in a matter of days. Under Operation Warp Speed, we’ve shaved years off of the time that it takes to develop a vaccine — in some cases, many years — and we’ve done it while maintaining the FDA gold standard for safety.”
“Four additional promising candidates are expected to enter final trials in the coming weeks, including the Novavax vaccine being developed right here at this facility. It’s an incredible facility.”
The Fujifilm facility which is being repurposed in order to help make the vaccines.
Repurposing Fujifilm to manufacture vaccines and ensuring complete oversight of the process is done to the highest FDA standards, here in the United States, ensures that the vaccine will meet the highest safety standards for human consumption. Currently, many of our medications come from China so this fact is sure to be very important to many consumers.
Trump said, “This production is made possible by my administration’s $1.6 billion award to Novavax as part of Operation Warp Speed.”
“These same manufacturing processes are being conducted on an even larger scale in College Station, Texas. Today, I’m proud to announce that HHS has just signed a $265 million contract with the Fujifilm-Texas A&M Innovation Center, which is quite the place, to dramatically expand their vaccine manufacturing capacity.”
In addition to the $1.6 billion investment in Novavax, the Trump administration has a given a $483 million contract to Moderna, a $1.2 billion contract to AstraZeneca, a $465 million contract to Janssen, and, just last week, a $1.95 billion agreement with Pfizer.
Trump said, “A groundbreaking agreement with Pfizer includes a guarantee to deliver 100 million doses shortly after the vaccine’s approval — almost immediately — with the option to purchase an additional 500 million thereafter.”
Usually, a vaccine is developed, then tested and then trials are run first with animals, then humans. Afterwards, the vaccine is produced en masse, then distributed.
President Trump explained, “Instead of the usual sequence of vaccine development, testing and trials, followed by production, our strategy is to conduct these phases simultaneously. So everything goes at one time.”
He also stated that the manufacturers have been tasked with producing all of the most promising vaccines in advance so that on the approval date, they will be immediately available to the public.
He expressed that he also wants enough vaccines to be able to ship to other countries to help those in need as well.
Trump also spoke about therapeutics as part of Operation Warp Speed to treat the virus. “Over 140 clinical trials are underway, and a number of effective therapies have already been developed and widely delivered, including remdesivir, which is having a tremendous impact, dexamethasone, convalescent plasma, and antibody treatments,” he said.
Regeneron’s antibody treatment program is in late-stage clinical trials and therefore should be ready fairly soon.
President Trump was quick to point out the fact that the mortality rate for patients over the age of 18 is 85 percent lower than it was in April. He attributed this to the medical advances and increased knowledge in how to treat the virus.
These statements, although true, are in direct conflict with what many other media sources have been dictating.
Trump said, “In the middle of April, more than 22 percent of all deaths in the United States were attributable to the China virus. As of last week, that number has dropped down — as of last week, it’s dropped down to under 7 percent.”
He also brought up the subject of decreasing turnaround time for test results in the form of what he called, ‘Pooled Testing’. “Samples from multiple patients are processed together.”
Trump said this would reduce turnaround time by more than 50%.
Concern for the most vulnerable population group, the elderly, led the Centers for Medicare and Medicaid Services begin distributing rapid point-of-care diagnostic test instruments to all of the nursing homes in the United States, the President said. With those testing kits, the response time is between five and fifteen minutes.
Trump spoke about the stockpile of PPE his administration has distributed all over the U.S. to ensure that all states have what they need and also mentioned the rise in cases in Mexico and South America that could potentially spread into Texas.
As a precaution, Trump said, “Beginning this week, Texas hospitals will receive 500 cases of Remdesivir, which has proven very effective, enough to treat 3,200 patients.”
Before moving into the question and answer phase, President Trump cautioned the younger Americans to be cautious of their actions to help slow down the spread to others who are more vulnerable.
Trump said, “I trust all Americans to do the right thing, but we strongly advise everyone to especially, especially focus on maintaining a social distance, maintaining rigorous hygiene, avoid large gatherings and crowded indoor bars, and wear masks when appropriate.”
Trump continued, “We also strongly urge citizens to take extra precautions to shield those at highest risk, which are, in most cases, in many cases, the elderly — especially the elderly with medical problems, such as heart or diabetes.”
“America will develop a vaccine very soon, and we will defeat the virus. We will have it delivered in record time.”